Next Article in Journal
Vitamin D Levels of Out-Patients in Lithuania: Deficiency and Hypervitaminosis
Previous Article in Journal
Typhoid Fever Diagnosis in Endemic Countries: A Clog in the Wheel of Progress?
Open AccessReview

Degenerative Aortic Stenosis, Dyslipidemia and Possibilities of Medical Treatment

Department of Cardiology, Medical Academy, Hospital of Lithuanian University of Health Sciences, Eivenių g. 2, 50161 Kaunas, Lithuania
Author to whom correspondence should be addressed.
Medicina 2018, 54(2), 24;
Received: 21 February 2018 / Revised: 19 April 2018 / Accepted: 20 April 2018 / Published: 25 April 2018
Degenerative aortic stenosis (DAS) is the most frequently diagnosed heart valve disease in Europe and North America. DAS is a chronic progressive disease which resembles development of atherosclerosis. Endothelial dysfunction, lipid infiltration, calcification and ossification are evidenced in both diseases. The same risk factors such as older age, male sex, smoking, and elevated levels of lipids are identified. The effect of smoking, visceral obesity, metabolic syndrome, hypercholesterolemia, low-density lipoprotein, high-density lipoprotein, lipoprotein(a), adiponectin and apolipoprotein(a) on development of DAS are being studied. The search for genetic ties between disorders of lipid metabolism and DAS has been started. DAS is characterized by a long symptom-free period which can last for several decades. Aortic valve replacement surgery is necessary when the symptoms occur. The lipid-lowering therapy effect on stopping or at least slowing down the progression of DAS was studied. However, the results of the conducted clinical trials are controversial. In addition, calcium homeostasis, bone metabolism and calcinosis-reducing medication are being studied. Although prospective randomized clinical trials have not demonstrated any positive effect of statins used for slowing progression of the disease, statins are still recommended for patients with dyslipidemia. Recent study has suggested that a specific modification of treatment, based on severity of disease, may have a beneficial effect in patients with aortic sclerosis and mild DAS. New clinical studies analyzing new treatment possibilities which could correct the natural course of the disease and reduce the need for aortic valve replacement by surgery or transcatheter treatment interventions are needed. View Full-Text
Keywords: degenerative aortic stenosis; lipoproteins; dyslipidemia; statins; medical treatment degenerative aortic stenosis; lipoproteins; dyslipidemia; statins; medical treatment
Show Figures

Figure 1

MDPI and ACS Style

Kleinauskienė, R.; Jonkaitienė, R. Degenerative Aortic Stenosis, Dyslipidemia and Possibilities of Medical Treatment. Medicina 2018, 54, 24.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop